SCHEMBL1959519

SCHEMBL1959519

CC1(C)CCC(CN2CCN(c3ccc(C(=O)N[S+]([O-])c4ccc(NN5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cc5cc[nH]c5cc4F)c3)CC2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 18/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1957867 0.93 BCL2 (0.83) BCL2
SCHEMBL1958776 0.91 BCL2 (0.83) BCL2
SCHEMBL1959527 0.91 BCL2 (0.84) BCL2
SCHEMBL1959548 0.91 BCL2 (0.82) BCL2
SCHEMBL1959045 0.91 BCL2 (0.83) BCL2
SCHEMBL1958007 0.90 BCL2 (1.00) BCL2
SCHEMBL1961131 0.90 BCL2 (0.83) BCL2
SCHEMBL1957705 0.88 BCL2 (0.82) BCL2
SCHEMBL1957262 0.87 BCL2 (0.73) BCL2
SCHEMBL1958129 0.86 BCL2 (0.83) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2507211-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2012-10-10 — — EP disclosed
WO-2011068560-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-06-09 — — WO disclosed
Send feedback